• Fulfilling


    With the Science of Enzymes

  • Fulfilling


    In the Treatment of 

    Gastrointestinal and Rare Diseases

  • Helping


    Fulfill Their Potential

News & Media

Alcresta Therapeutics Receives 510(K) Clearance For Use of RELiZORB® in Children

Jul 20, 2017

RELiZORB, The Only Digestive Enzyme Cartridge for Patients Requiring Supplemental Enteral Nutrition, Now Cleared to Help Children Suffering
From Fat Malabsorption

Alcresta Therapeutics’ RELiZORB™ Increases Fat Absorption in Adult and Pediatric Patients with Cystic Fibrosis Receiving Enteral Nutrition

Oct 28, 2016

RELiZORB significantly increased plasma levels of DHA and EPA fatty acids and patients report a decrease in the frequency and severity of gastrointestinal symptoms

RELiZORB™ Recognized for Medical Design Excellence

Jul 26, 2016

Alcresta Therapeutics’ RELiZORB, a first-of-its kind digestive enzyme cartridge designed to mimic the function of pancreatic lipase, was selected as the Gold Winner at the Medical Device Excellence Awards (MDEA).